Clinical Study
Staged Mucosal Advancement Flap versus Staged Fibrin Sealant in the Treatment of Complex Perianal Fistulas
Table 1
(a) Patient characteristics of the fistula. (b) patient characteristics.
(a) |
| | MF | FS | | | | | |
| 1 fistula track | (27%) | (67%) | | 2 or more fistula tracks | (73%) | (33%) | | Abscess | (13%) | (0%) | | Residual inflammation and prolonged seton treatment | (20%) | (27%) | |
|
|
(b) |
| | MF | FS | | | | | |
| Sex | Male (67%) | Male (73%) | | Female (33%) | Female (27%) | Age (years) | 51 (range 39–70) | 45 (range 30–68) | | Median followup (months) | 52 (46–60) months | 49 (49–59) months | | Tobacco smokers | (40%) | (53%) | | Soiling (before treatment) | (13%) | (20%) | |
|
|